Clonal deletion provides an important mechanism for the elimination of autoreactive T cells. Deletion is accomplished by programmed cell death directed by interaction of the T-cell receptor (TCR) of the developing thymocyte with major histocompatibility complex elements in the thymic environment. In this report we present evidence to support the hypothesis that the activation and the maturation state of the T cell may be important in coupling the TCR to the "death program." We show that coupling of the TCR to the death program is open during maturation but closed in naive mature T cells. However, during primary antigenic stimulation, coupling between the TCR and the death program is reopened, as demonstrated by the stimulation of the death of these cells by immobilized anti-TCR. Our results suggest that further examination of mature cells that are either resistant or sensitive to receptor-stimulated death may lead to the identification of the components of the death pathway and may provide clues to the regulation of their coupling to TCR signals.
Death of specific cells plays a major role in shaping morphological and functional maturity in a variety of systems. It is active in tail resorption, digit and neuronal network formation, and clonal deletion of autoreactive T cells. A major question in T-cell biology is how the T-cell receptor (TCR) can stimulate both positive selection and death of autoreactive cells (clonal deletion). These seemingly antagonistic responses appear to be regulated during ontogeny by the interaction of the thymocyte-TCR complex (the clonally distinct chains ofthe TCR with its associated pan-T-cell-CD3 complex) with its environment (1) (2) (3) . Based on these experiments (1-3), both positive selection and negative selection appear to require, in addition to TCR stimulation, an interaction of thymic stromal major histocompatibility complex class I or class II antigens with CD8 or CD4, respectively, on the surface of the developing thymocyte. This complex interaction in the developing thymocyte is, therefore, homologous to that required in the periphery for activating a functional (lytic, proliferative, or lymphokine secretion) T-cell response.
Deletion of autoreactive T cells apparently occurs because the signaling pathway between the TCR and the "death
program" is open during development. Smith et al. (4) have observed that a monoclonal antibody (mAb) directed at the CD3 complex caused death of immature thymocytes in organ culture but stimulated proliferation of mature T cells. Thus, signals from the TCR may activate different genes depending on the maturation state of the cell. In this report, we demonstrate that the activation as well as the maturation state of the T cell may be important in coupling the TCR to the death program.
Experiments from this laboratory with cytotoxic T-lymphocyte (CTL) clones (5), from Nau et al. (6) with CD4' clones, and from Ashwell et al. (7) with hybridomas indicated that the TCR could have a negative effect on proliferative responses of mature T cells. For the hybridomas, a high dose of antigen or anti-TCR antibodies clearly induced cell death and was capable of selective toxicity in vivo. This phenomenon, which results in the relatively rapid death of the responding cell, therefore, is clearly distinct from the "anergic" response of type 1 T helper cells lacking "costimulator" activity (8) . In the hybridoma system and the CD8' system described below, death of these peripheral T cells is initiated by the TCR, and, since other events during differentiation appear to be homologous to the activation of peripheral cells, understanding TCR-stimulated death in peripheral T cells may be important both in maintaining the repertoire selected in the thymus and in understanding the process of clonal deletion in the thymus.
An interesting observation in the hybridoma system was that prior to initiating the death pathway, the antigen or anti-TCR altered the transit of the hybridomas through the cell cycle by creating a blockade at the G1/S boundary (9) . The observation that the cell cycle status of the responding T cell may influence the functional outcome may have important analogies within the thymus. Penit and colleagues (10, 11) have determined that immature thymocytes undergo at least one and possibly two periods of proliferation that culminate in selection. Similarly, the thymic injection experiments of Guidos et al. (12) indicate that the selected cells come from the blast-like subset of CD4+/CD8' thymocytes.
Thus regulation of the cell cycle within the thymus is poorly understood but may also play an important role in selection.
EXPERIMENTAL PROCEDURES
Mice. C57BL/6J, DBA/2J, and BALB/cJ (The Jackson Laboratory) or H-2b mice expressing a transgenic TCR for H-2Ld as described (2) were used in all experiments. The transgenic TCR originated from the 2C CTL line and is recognized by mAb 1B2 (13) .
Cell Culture. RPMI 1640 medium-based medium supplemented with 5% (vol/vol) heat-inactivated fetal calf serum, 2 mM glutamine, 15 mM Hepes, nonessential amino acids (GIBCO, 10Ox), 1 mM sodium pyruvate, penicillin (2.5 x 104 units/liter), and streptomycin (25 mg/liter) was used in all experiments. Immulon I plates (Dynatech) were sterilized and coated with mAb purified from ascites fluid or tissue culture medium, and unbound sites were blocked with bovine serum albumin as described (14) . Antibodies used were the anti-clonotype mAb 1B2 (anti-TCR) described above, the anti-CD3 mAb 2C11 (15) , or the anti-CD8 mAb 53-6.72 (16) .
In some experiments, CD8' cells were enriched by nylon Abbreviations: CTL, cytotoxic T lymphocyte; TCR, T-cell receptor; mAb, monoclonal antibody; IL-2, interleukin 2.
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wool adsorption and elimination of residual B cells and CD4' cells with mAb Jild (17) [3H]Thymidine Incorporation. Triplicate cultures of 1-5 x 104 cells were incubated in 0.2 ml of medium containing recombinant interleukin 2 (IL-2; Cetus) at 10 units/ml for 3 days. The last 4 hr cells were pulse-labeled with [3H]thymidine (1 ,uCi per well; 1 Ci = 37 GBq) before harvesting on glass-fiber filters.
EXPERIMENTAL RESULTS
Anti-TCR or Anti-CD3 Stimulated Proliferation of Naive Splenocytes but Blocked Proliferation of Activated Splenocytes. A comparison of immobilized anti-TCR or anti-CD3 on a cloned CTL line or transgenic splenocytes previously activated by antigen (mixed lymphocyte culture) demonstrated these mAbs have a strong negative effect on proliferation in response to IL-2 alone. In contrast, naive splenocytes were stimulated to proliferate under nearly identical conditions ( Fig. I A-C) . Even the highest doses of mAb were unable to produce a negative response in the naive populations.
One potential explanation for the failure to observe the inhibitory effects of anti-TCR or -CD3 on naive cell proliferation could be that they are more refractory to TCR stimulation and require much higher levels of mAb to produce the same effect. We had found (14) that coimmobilization of anti-TCR and anti-CD8 could increase the sensitivity Anti-CD3, ,ug/ml of naive cells to anti-TCR by as much as 10,000-fold, as indicated by a parallel shift (both maximal and half-maximal concentrations) in the concentration-effect relationship of anti-TCR and proliferation. In Fig. 1 D and E, we have taken advantage of this observation to demonstrate that this increased sensitivity to TCR by immobilized anti-CD8 increased the sensitivity of previously activated cells to anti-TCR inhibition ofproliferation but still was unable to produce a negative effect on naive splenocytes. These data suggest that a qualitative rather than a quantitative difference in responsiveness exists between naive and activated splenocytes.
Anti-TCR or Anti-CD3 Stimulated Death of AntigenActivated Splenocytes. The mechanism of the block in proliferation of activated splenocytes was further investigated by assessing the viability of cells after incubation on plates coated with anti-CD3 or anti-TCR (1B2). Fig. 2 demonstrates that anti-CD3 caused death in both transgenic and conventional CD8+ splenocytes. In contrast, the anti-TCR specific for the transgenic T cells selectively caused death in the transgenic population. In other experiments, this effect was demonstrated to be specific for anti-TCR or anti-CD3 because anti-CD8 had no effect on cell viability (data not shown).
An important question was whether the lytic effect of the anti-TCR or anti-CD3 was selective for the stimulated population or was the result of nonselective toxic products released by TCR stimulation. This was tested in a mixing experiment in which transgenic CD8+ cells were mixed with a conventional CTL clone. Both populations were equally sensitive to this concentration of immobilized anti-CD3 ( Fig.  1 A and B) . However, when the cells were mixed on immobilized 1B2 (specific for the transgenic clonotype), the transgenic cells were selectively-depleted (compare Fig. 3 One ofthe most striking phenomena ofTCR-stimulated death in the hybridoma system is the accumulation of cells at the G1/S boundary of the cell cycle. Fig. 4B demonstrates that antigen-activated CD8' cells also accumulated with a DNA content associated with the G1/S boundary of the cell cycle. In this experiment, control and anti-TCR stimulated cells were analyzed for DNA content per cell by fluorescenceactivated cell sorter after staining with propidium iodide. Mercep et al. (25) have demonstrated that the G1/S blockade can occur in the absence of death in the hybridoma system. However, there is no evidence to indicate that TCRstimulated death can occur in the absence ofa G1/S blockade. Thus it is possible that specific points of the cell cycle are essential for either the production of TCR-stimulated toxins or the targets of such toxins. These experiments further highlight the potential importance of cell cycle regulation during thymic development for the process of selection to occur.
Antigen but Not Anti-TCR Primed Splenocytes for Subsequent TCR-Stimulated Death. The experiments above raised several questions. The cell cycle experiments raised the question of whether activation and entry into cycle were sufficient to produce sensitivity to TCR-stimulated death. In addition, immobilized anti-TCR produced positive and negative effects on naive and activated splenocytes, respectively. Similar amounts of immobilized anti-TCR have been used in limiting dilution experiments (14) . Thus it was difficult to imagine how toxic concentrations of immobilized anti-TCR could allow the development of clones.
We resolved these issues by examining the sensitivity to TCR-stimulated death of splenocytes initially activated by either antigen or anti-TCR. In both cases, cells were harvested after 4 days of stimulation, allowed to recover overnight in the absence of antigen or anti-TCR, and retested for sensitivity to immobilized anti-TCR. The results (Fig. 5) demonstrate that antigen-activated cells became sensitive to TCR-stimulated death within a few days of antigen exposure. In contrast, anti-TCR primed cells remained resistant to TCR-stimulated death. Trivial explanations that we have considered for this finding were as follows: (i) TCR modulation during anti-TCR priming; (ii) a TCR signaling defect in the anti-TCR-primed population; and (iii) selective expansion of a subset of cells by either priming regimen. However, none of these trivial explanations appear to be valid. Both primary populations expressed similar levels of TCR by fluorescence-activated cell sorter analysis (data not shown). Similarly, a signaling defect in the anti-TCR-primed population seems CD8' cells from the same spleen were enriched by nylon wool purification followed by anti-CD4 and Jild treatment plus complement. The CD8+-enriched population was primed on wells coated with 1B2 (10 gg/ml). Both populations were stimulated for 4 days in the presence of IL-2 (10 units/ml), harvested, and incubated in uncoated wells for an additional 24 hr [also in medium containing IL-2 (10 units/ml)] before plating in IL-2-containing medium on control wells or wells coated with 1B2 (anti-TCR; 10 gg/ml). After 24 hr cells were harvested, viability was determined by trypan blue exclusion, and cells were stained for TCR expression with 1B2. Greater than 85% of both populations were 1B2' with identical levels of expression (data not shown).
can have TCR signals coupled to the death response. The ability of the hybridomas to die in response to TCR stimulation may reflect an intrinsic property of the BW5147 parent or may reflect a property of the nontransformed fusion partner. In most cases, the fusion partner is an activated T cell. Thus the hybridoma may rescue and perpetuate the sensitive phenotype by constitutively expressing the elements necessary for coupling the TCR to the death pathway.
An important question is whether the death stimulated by immobilized anti-TCR or anti-CD3 is physiologically relevant. Certainly, immobilized anti-TCR or anti-CD3 is a nonphysiological stimulus. However, the data presented above indicate that it is a useful tool in determining if TCR coupling to the death pathway is present. Further, the data indicate that TCR coupling to the death pathway is not necessarily restricted to immature T cells.
Other experiments (J.H.R., unpublished data) indicate that although precursor frequencies vary somewhat from animal to animal, the ratio of the precursor frequencies for naive transgenic cells stimulated by antigen or anti-TCR is nearly one. Similarly, that precursor frequency remains relatively constant for antigen-primed cells when antigen is used as a secondary stimulus. In contrast, the precursor frequency of antigen-primed cells assayed with anti-TCR as a secondary stimulus falls >100-fold within 1 week and >10-fold within 4 days of antigen priming. Thus responsiveness to nominal antigen is not affected by the primary activation. However, studies with heteroclitic clones indicate that higher-avidity forms of antigen (as assessed by cold target inhibition) do inhibit the expansion of CTL clones (5, 27) . Therefore, a secondary stimulus with higher-avidity antigen, such as anti-TCR, may also stimulate death in primary cells. This phenomenon could serve as a mechanism to limit affinity maturation of clones by mutation to higher-avidity specificities not originally selected in the thymus.
The results above indicate that the coupling of the TCR to an endogenous death pathway can be regulated by interaction Proc. Nati. Acad. Sci. USA 88 (1991) 2155 with other cells, even in terminally differentiated T cells. Given the increasing number of homologies between selection of developing thymocytes and antigen activation of peripheral cells, we would suggest that the conversion of naive splenocytes from TCR-stimulated death-resistant to -sensitive phenotype by antigen may reflect a homologous property of the thymic environment on developing thymocytes. Thus some interaction between a developing thymocyte and its environment may be required before it becomes sensitive to clonal deletion.
Neither the nature of the elements coupling the TCR to the death program nor the mechanism of death is identified here. However, Fig. 3 demonstrates that death is selective for cells of the same clone rather than the nonselective death of all potentially sensitive clones in the culture. Therefore, death is either the result of TCR-stimulated suicide or fratricide in which TCR stimulation is required to both activate and sensitize similar cells. The limiting dilution analysis discussed above argues against a fratricidal mechanism requiring cell contact. The availability of cell populations of the same clonotype expressing the sensitive and resistant phenotypes should assist in efforts to identify the elements responsible for death and the subsequent understanding of their regulation.
